Migraine Prevention

AHS/AAN Migraine Prevention

AAN GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/61838

Contents of this Issue

Navigation

Page 5 of 7

Treatment Coexisting Conditions ÎTake coexisting conditions into account. Some (comorbid) conditions are more common in persons with migraine (e.g., stroke, myocardial infarction, Raynaud's phenomenon, epilepsy, affective and anxiety disorders). These conditions present both treatment opportunities and limitations. ÎSelect the best drug to treat each disorder. Therapeutic independence may be required—i.e., avoid picking a less-effective drug in order to treat more than one disorder with a single medication. ÎEstablish that the treatments being used for migraine are not contraindicated for the coexistent disease. ÎEstablish that the treatments being used for coexistent conditions do not exacerbate migraine. ÎBeware of all drug interactions. ÎDirect special attention to women who are pregnant or want to become pregnant. Preventive medications may have teratogenic effects. If treatment is necessary, select a treatment with the lowest risk of adverse effects to the fetus. Nonpharmacologic Treatments ÎMany migraine patients try nonpharmacologic treatment to manage their headaches before they begin drug therapy or concurrently with drug therapy. Clinical Considerations Coexisting Factors Anorexia ÎCaution should be taken in using topiramate in thin or anorexic patients because it may exacerbate weight loss. By contrast, these patients may benefit from valproic acid, divalproex sodium, or a tricyclic antidepressant. Asthma ÎPropranolol and other beta-blockers may have adverse effects on patients with asthma. Bipolar Disorder ÎA person with coexistent bipolar disorder might benefit from valproic acid, assuming that he or she does not have underlying liver disease, thrombocytopenia, or pancreatitis and is aware of the risk of alopecia and weight gain.

Articles in this issue

Archives of this issue

view archives of Migraine Prevention - AHS/AAN Migraine Prevention